expanding Globus Medical's reach into the musculoskeletal market, particularly in neuromodulation technology and chronic pain treatment solutions. Management reaffirmed 2025 revenue guidance of $2 ...

About Globus Medical, Inc. Based in Audubon ... unless the underlying item has a materially different tax treatment, in which case the estimated tax rate applicable to the adjustment is used.

Globus Medical will hold a teleconference to ... unless the underlying item has a materially different tax treatment, in which case the estimated tax rate applicable to the adjustment is used.

Globus Medical reported its financial results for Q1 2025, revealing a miss on both earnings and revenue forecasts. The company posted an earnings per share (EPS) of $0.68, falling short of the ...

NEW DELHI: Globus Spirits Ltd, known for its Terai gin and Doaab single malt, is looking to expand into new categories, including beer and additional variants of single malt whisky, as part of its ...

The company’s products are designed to offer “minimally invasive” treatment alternatives for individuals with chronic sacroiliac joint pain. Globus Medical CEO and president Dan Scavilla said: “We are ...

Globus Medical (NYSE ... of Nevro’s differentiated high-frequency technology and bringing a much-needed treatment option to patients suffering from chronic pain,” said Dan Scavilla, president ...

The primary treatment strategies include medication adjustments ... Non-pharmacologic interventions include deep brain stimulation, which targets the globus pallidus or subthalamic nucleus and has ...

Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...

Cory McGillivray, senior director of sales operations and channel marketing for the Globus family of brands, called 2025 the company's "year of the travel advisor." In keeping with that theme ...

Globus Medical will showcase its products and innovations at the AAOS Annual Meeting in San Diego from March 10-14, 2025. Globus Medical, Inc. announced its participation in the 2025 Annual ...

Globus Medical plans to discuss the closing ... that continue to set the standard for enduring patient outcomes in the treatment of chronic pain. Nevro's comprehensive HFX spinal cord stimulation ...